DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ff22ab/gynecological_canc) has announced the addition of John Wiley and Sons Ltd's new report "Gynecological Cancer Management: Identification, Diagnosis and Treatment" to their offering.
This concise and practical guide enables the gynecologist to differentiate between benign and malignant gynecologic conditions to determine the best management options for the patient.
Over the past three decades, as the specialty of obstetrics and gynecology has matured into a broad and diverse group of skills and disciplines, it has become apparent that there are diagnoses and conditions in gynecologic oncology where the obstetrician-gynecologist has a level of uncertainty, or lack of confidence in his ability or knowledge base to adequately manage the patient and therefore refers the patient to a gynecologic oncologist.
This text portrays the advances in the field and reviews the current management of a number of gynecologic conditions to give the reader the confidence needed to deal with these issues.
The distinguished Editors have crafted the book to include:
Case vignettes to provide clinical context Pathology notes to aid diagnostic outcomes Management guidance for obgyn practitioners to enable the best outcome for their patients Each topic is introduced with a concise overview followed by case-based scenarios which discuss the specific management of common problems.
Providing the general gynecologist with the current clinical information necessary to manage conditions and identify the situations where consultation or referral to a gynecologic oncologist would be in the patients best interest.
Key Topics Covered:
2. Vulvar Intraepithelial Neoplasia (VIN).
3. Vaginal Intraepithelial Neoplasia (VAIN).
4. Cervical Intraepithelial Neoplasia (CIN).
5. Microinvasive Carcinoma of the Cervix.
6. Endometrial Hyperplasia.
7. Unusual neoplasms of the uterus.
8. Evaluation and management of the adenxal mass.
9. Management of the patient at high risk to develop ovarian cancer.
10. Borderline Ovarian Tumors (Ovarian cancer of low malignant potential).
11. Management of apparent early stage epithelial ovarian cancer.
12. Germ Cell Tumors.
13. Unusual ovarian neoplasms.
14. Diagnosis and management of H. Mole, partial mole.
For more information visit http://www.researchandmarkets.com/research/ff22ab/gynecological_canc.